Food Safety Assessment Techniques for Cultured Meat - Part I
In the context
of cultured meat processing, the toxicity testing required for cultured meat products
or specific inputs in the manufacturing process and their extent are yet to be developed.
The safety of the final product including cultured meat as an ingredient, additive,
or whole food, is to be established through a safety assessment of the inputs
and then an evaluation of the types and levels of residues, by-products, and
metabolites remaining in the final product will be necessary. If deemed to have
a significant novel or unique properties, an assessment of the final product
itself as a whole may be needed.
Many
existing standard toxicity testing methods can be used to assess inputs. However,
any inputs into food must be of food-grade quality, meeting specifications and
criteria specific to that ingredient specified in the Codex Alimentarius or
such relevant standard. Thus, the development of specifications for cultured
meat and additives, such as
scaffold materials, may be warranted. Approaches to safety testing of
ingredients and food additives are well established, using biochemical, in
silico, in vitro, and in vivo methods. Globally harmonized testing standards such
as those developed by the Organisation of Economic Co-operation and Development
(OECD), World Health Organization (WHO), Food and Agriculture Organization
(FAO), or regulatory organizations may be applied directly or modified for use
in the cultured meat safety testing
context. Tests and analyses under these standards are generally carried out
following Good Laboratory Practice (GLP), a set of principles designed to
assure study quality and integrity.
According
to the European Food Safety Authority and U.S. Food and Drug Administration, products
that have compositional, nutritional, and functional equivalency to already
accepted foods are in theory as safe as the products to which they are
equivalent. Hence, the comparison then relies on the history of safe use and
data supporting the safety of the conventional food, where any identified
differences will direct further safety testing. It is expected that some cultured
meat products will not be the same as their conventional counterparts. In fact,
if a cultured meat product may contain synthetic scaffold materials or other
novel inputs, or the cells may be genetically modified such that new proteins
are expressed or existing proteins are under- or overexpressed, and the
biochemistry and composition of those proteins may vary. Thus, toxicity testing
may be required to demonstrate the safety of inputs and components in the final
product accordingly.
Thus,
there are various existing technologies and analytical methods have bee already
adapted or modified to synergize with current and proposed developments in the safety
aspects of cultured meat. Hence, the following methods represent brief gross
explanations of some of the critical analytical methods that are already in practice
for the evaluations.
Microbiological
Analysis
Generally,
microbiological limits are established for conventional livestock or
aquaculture products throughout the world and guidance has been developed to
help identify microbiological hazards in meat, poultry, seafood, and other
animal proteins by various organizations such as the U.S. Department of
Agriculture, FDA, FAO/Codex Alimentarius, WHO, etc. Bacterial and viral
contamination may be detected through routine process monitoring such as physicochemical
changes, pH shifts, and changes in turbidity, where compromised cell cultures
can signal contamination. Theoretically, existing standards, guidelines, and
specifications for microbiological characterization are mostly applicable,
which employs conventional techniques such as plate counting methods or immunoassays,
as well as more efficient techniques including molecular methods such as
polymerase chain reaction, and enzyme-linked immunosorbent assays (ELISA). Nonetheless,
biosensor technology may also be applied in real-time to screen and detect
microbial contamination of meat products in case required, as well as there are
commercially applicable standard methods exist to detect and quantify common
microbiological hazards, such as Salmonella, Listeria, and E.
coli.
Further
guidance on the evaluation of viruses and mycoplasma in products derived from
cell lines of animal origin is available for biotechnological products, where infectivity,
electron microscopy, reverse transcriptase, antibody production tests, and in
vitro assays using susceptible indicator cells may be used to detect viruses. In
addition, mycoplasma can be assessed using nucleic acid amplification technique-based
assays, DNA staining, and culture methods, but currently, it is unknown whether
cultured meat product manufacturing may pose any unique microbiological
hazards, as no novel pathogens are expected.
On contrary,
microbiological challenge testing may be a useful approach to evaluate any
potential hazards arising from storage or food processing. In challenge testing,
pathogenic organisms are intentionally introduced to a given food, then
products are treated or stored under realistic conditions and analyzed for any
physicochemical changes, microbiological growth, or hazardous degradation
products, which can provide information on product stability and the
effectiveness of procedures designed to eliminate pathogens.
Residue,
Contaminant, and By-product Analysis
Even
though some substances are not intentionally included in the final product, there
are various substances that are intended to be used during the manufacturing process
that could carry residues over to the final products. Thus, the presence of any
drugs such as antibiotics, additives, processing aids, and contaminants needs
to be considered and analyzed. Limits and maximum impurity or residue levels for
general residues such as metals, natural toxins, agricultural or veterinary
chemicals, and environmental contaminants are already established for
conventional livestock or aquaculture products in many jurisdictions and can be
used as it is or with slight modifications. As a matter of fact, a list of
antimicrobials that should not be used in animals due to their critical
importance for human medicine has been already developed and adopted by the
World Health Organization (WHO). Most antibiotic drugs currently approved for
use in food animals are also approved for human use, but if these existing
criteria for conventional products require additions or modifications for cultured
meats remain to be determined.
If new
processes or techniques are incorporated those novel inputs may need to be
validated through existing or specific techniques developed to conduct analytical
tests to identify any residues, contaminants, or by-products in the final
product. The conventional inputs with known chemical hazards such as
dissociation reagents and cryoprotectants may be screened using conventional
analytical methods such as mass spectrometry, chromatography, and immunological
techniques, though sample preparation may require modification for the cultured
meat matrices. Bioassays that are already used to detect a wide range of
residues in conventional meat products such as a multiple bioassay method
designed to screen meat and poultry for common antibiotic groups (U.S.
Department of Agriculture) can be easily applied and after which the specific
techniques can be used for full identification and quantification. Bioassays
may also be used as a screening tool for currently unknown or unexpected
hazards, where determining whether the sensitivity and range of the tests are
adequate for the various inputs used in cultured meat products, or whether the
techniques will require modification, is an important factor in improvements for
future.
Biochemical,
Molecular, Physical, and Compositional Analyses
Biochemical,
molecular, physical, and compositional analyses are another major aspect of
cultured meat products which can be used as part of a comparative approach to
assess the similarity to existing products. Hence, GE food and feed and cloned
animals intended for food are analyzed using specific safety assessment techniques
that can be anticipated to apply to cultured products, whether the given
product is genetically modified or not.
the
extent of any differences in the genome and confirmation of intentional effects
or identification of unintentional expressions of products not normally seen in
meat or seafood can be determined using molecular and biochemical analysis of cultured
meat products. Any differentiated expression of products found can be compared
to conventional products to identify any new or increased hazards related to
consumption. For example, a safety assessment of a GE fish, AquAdvantage
salmon, and a GE pig, GalSafe pig, determined that the introduced DNA was safe
for the resulting GE animal and its offspring and that the animals are safe to
eat. The safety assessments relied on determining the health of the animal, as
a healthy animal is likely to be safe to eat, where phenotypic characterization,
as well as compositional and nutritional analysis of the edible tissues, must
be performed to ensure that there were no biologically relevant differences
between the GE animals and comparator conventional animals.
Methods
already exist to characterize GE animals intended for use as food, where the
genome sequence is evaluated to determine whether the inserted genetic material
changes essential gene function, as part of this analysis it is intended to
identify whether there are new and unintended open reading frames or not and to
ensure that no genes code for known toxins or antinutrients. The biochemical
and proteomic analyses already exist to assess the expression of new products
and identify differences in protein, peptide, amino acid, and metabolite levels
as compared to conventional meats, where any newly expressed or altered
proteins may affect product stability or physical properties and alter their
toxic or allergenic potential. The assessment of a novel protein may focus on
amino acid sequence similarity to known toxins or allergens and an if
significant homology is found, then further testing may be performed to understand
stability or digestibility in the human body and toxicity testing of that
protein.
The cells
themselves are typically monitored throughout the process for quality control
measures, which can provide an indication of cell health. For example,
physicochemical properties, proliferation potential, differentiation capacity,
karyotype stability, and the expression of specific cell markers to validate
identity can provide valuable safety information and identify any unwanted
physicochemical transformations.
A compositional
analysis is mainly considered to be a key element of a comparative safety
assessment, which may include an assessment of macro- and micronutrients,
bioactive compounds, toxins, and allergens that can provide a baseline to
compare cultured meat with a conventional product. Because products that are
similar to conventional meat products are more likely to be processed and
metabolized similarly and may rely on the safety assessment of their conventional
counterpart.
https://ift.onlinelibrary.wiley.com/doi/full/10.1111/1541-4337.12853
https://www.foodincanada.com/features/the-food-safety-advantages-of-lab-grown-meat/
https://www.frontiersin.org/articles/10.3389/fnut.2020.00007/full
https://www.centerforfoodsafety.org/blog/6458/is-lab-grown-meat-healthy-and-safe-to-consume
https://www.mdpi.com/2304-8158/10/12/2922